Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision tag in the footer was updated from v3.6.4 to v3.6.5, indicating a minor metadata update to the page.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now displays a newer revision number (v3.6.4) in place of the previous v3.6.3, indicating a small update to the site's interface.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, indicating a newer version of the page has been published. This suggests a minor update to the page metadata or content.SummaryDifference0.1%

- Check87 days agoChange DetectedRecruitment status on the study page now indicates no longer looking for participants. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label formatting plus the page revision to v3.6.0 (from v3.5.4) were updated.SummaryDifference0.5%

- Check108 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a small backend/format update; no visible changes to the study details are expected.SummaryDifference0.1%

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.